Join the Hypoparathyroidism group to help and get support from people like you.
Hypoparathyroidism News
FDA Approves Yorvipath (palopegteriparatide) for the Treatment of Hypoparathyroidism in Adults
COPENHAGEN, Denmark, Aug. 12, 2024 (GLOBE NEWSWIRE) – Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food & Drug Administration (FDA) has approved Yorvipath (palopegteriparatide;...
FDA Approves Natpara (parathyroid hormone) for Hypocalcemia in Patients with Hypoparathyroidism
January 23, 2015 – The U.S. Food and Drug Administration today approved Natpara (parathyroid horomone) to control hypocalcemia (low blood calcium levels) in patients with hypoparathyroidism, a rare...